In this video, Vinson & Elkins’ Partners Craig Seebald and Zach Terwilliger delve into the government investigations portion of our latest Antitrust Cartel Primer.
On this podcast episode, Bloomberg’s Joe Weisenthal and Tracy Alloway speak with V&E Antitrust partner and Litigation/Regulatory Department co-head Craig Seebald to understand how the law in this space gets applied.
Nearly a year and a half after the passage of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”)1 on March 27, 2020, the Special Inspector General for Pandemic Recovery (“SIGPR”) has ramped up and is investigating fraud related to the U.S. government’s pandemic relief efforts.
The Department of Justice’s (“DOJ”) Procurement Collusion Strike Force (“PCSF”) chalked up several more prosecutions soon after we reported its first-ever international resolution — a guilty plea from Belgium-based G4S Secure Solutions NV (“G4S”) on June 25, 2021.
In recent years, the Securities and Exchange Commission (the “SEC”) has increasingly brought enforcement actions against chief compliance officers (“CCOs”) in their personal capacities.
As discussed in our recent blog post, the Criminal Antitrust Anti-Retaliation Act of 2019 (“CAARA”) was, earlier this year, assigned for implementation to Occupational Safety and Health Administration’s (“OSHA”) Whistleblower Protection program.
The recent Criminal Antitrust Anti-Retaliation Act (CAARA), to be enforced by the Occupational Safety and Health Administration (“OSHA”), offers protection from retaliation for antitrust whistleblowers who come forward to report possible criminal violations internally or directly to government authorities.
In a striking rebuke, the U.K. Supreme Court found that the U.K. Serious Fraud Office (“SFO”) overstepped its authority when it tried to access corporate documents from the United States.